Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Innovent registers Phase 1 trial of IBI3046 in Chinese patients with overweight or obesitySep 9Trial updateInnovent Biologics
OPKO Health amends note agreement, issues $125 million in additional senior secured notesAug 14FinancingOPKO Health, Inc.